Julia S. Kovaleva

Julia S. Kovaleva

Auto-generated profile, based on publicly available information

Julia S. Kovaleva

Altai State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
JKJ. S. Kovaleva
J. S. Kovaleva
OKO. A. Kokina
O. A. Kokina
TST. N. Shepileva
T. N. Shepileva
Acne is one of the most common dermatoses, especially among young people. The worldwide prevalence reaches up to 80% of young people aged 15 to 17 who have symptoms of acne, and the condition often persists into adulthood. In the pathogenesis of acne, in addition to pathological hyperkeratosis and inflammation, an important role is played by such factors as massive microbial contamination, species composition, biological properties of pathogens, in particular, their drug resistance. For the treatment of acne of moderate and severe severity, antibacterial drugs are used – tetracycline, erythromycin, doxycycline. These drugs have a bacteriostatic effect on Cutibacterium acnes by inhibiting the synthesis of bacterial proteins. Antibiotics for acne demonstrate antimicrobial and anti-inflammatory effects and act in two directions: they reduce the colonization of C. acnes and inhibit the production of inflammatory mediators associated with С. acnes. Side effects in antibiotic treatment are rare, but the main problem in their appointment is resistance, the frequency of which is increasing every year. The review part of the article presents the literature data of domestic and foreign authors on the formation of С. acnes resistance to antibiotic therapy in acne patients in the process of therapy evolution. Cause-and-effect relationships of the formation of resistance in the application of antibacterial drugs of various classes are described. The strategy and tactics of a doctor to limit the spread of C. acnes antibiotic resistance are considered. A special place in the article is given to the important role of benzoyl peroxide, clindamycin and the synergistic effect of the fixed combination of clindamycin / benzoyl peroxide in overcoming the resistance of С. acnes and achieving the effectiveness and safety of therapy. The second part of the article presents our own clinical observations of the effectiveness of the domestic combined preparation of the Klindavit Combo gel (clindamycin / benzoyl peroxide) in the treatment of patients with papulopustular acne who are on outpatient treatment by a dermatologist.

15 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
JKJ. S. Kovaleva
J. S. Kovaleva
NKN. G. Komkina
N. G. Komkina
The relevance of microbic eczema is caused by prevalence of a disease, a long chronic current, frequent, is long the proceeding recurrence, insufficiently studied pathogeny and difficulties of the choice of effective treatment. Microbic eczema – the chronic recurrent dermatosis which is characterized by evolutionary polymorphism of elements of rash, wet an itch and a peculiar allergic reaction of the sensibilized skin to decomposition products of microorganisms and their toxins arising against the background of it is long the existing piogenic center at disturbance of the major regulatory systems of an organism. At patients with microbic eczema disbioz skin it is shown by reduction of a share of S. epidermidis, Bifidobacterium spp., Lactobaccilus spp. and significant increase in opportunistic and pathogenic flora, associations of mushrooms quite often meet representatives of obligate flora. Allergenic action of S. aureus and fungal microflora, in particular, of C. Albicans at microbic eczema considerably amplify in the conditions of a mikstinfektion. In recent years microbic eczema tends to a heavy current with a frequent long recurrence, considerable distribution of process on skin and is characterized by resistance to the standard methods of treatment. Elimination of action of microbic, mycotic dissimination and normalization of a biocenosis of skin at microbic eczema are the key principle of treatment of patients interfering recuring of chronic eczema. The article focuses on microbial eczema, as the most difficult type of eczema in therapy, presents our own clinical observations of the course of microbial eczema of various localization and severity, and also shows the effectiveness of the Russian-made topical drug Akriderm GK, containing a micronized form of betamethasone dipropionate, gentamicin sulfate and clotrimazole in the complex therapy of patients with microbial eczema.

1 January 2021 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
JKJu.S. Kovaleva
Ju.S. Kovaleva
SRS.V. Reshetova
S.V. Reshetova
MNM.G. Nikolaeva
M.G. Nikolaeva
Розацеа — хронический дерматоз воспалительного характера, характеризуемый транзиторной эритемой, папулами и/или пустулами, телеангиоэктазиями, фиматозными изменениями и такими основными субъективными симптомами, как зуд и жжение. В 2017 г. экспертной комиссией Американского национального общества по розацеа рекомендован фенотипический подход к диагностике и классификации данного заболевания, и с их обновлением варианты лечения пациентов с розацеа претерпели некоторые изменения. Эффективность терапии клинических форм розацеа достигается использованием различных комбинаций лекарственных средств и методик, однако нельзя не учитывать провоцирующие экзогенные факторы и коморбидный фон. Розацеа считается дерматологическим заболеванием, но тем не менее накапливаются доказательства значительной связи между розацеа и системной соматической патологией. В обзоре мы обобщаем новые научные данные о патогенезе заболевания, в частности о роли провоспалительных нейропептидов, сочетании ряда соматической патологии с течением и тяжестью розацеа. Описаны данные российской и зарубежной литературы по лечению розацеа с акцентом на местную терапию с учетом конкретных подтипов дерматоза, а также группы препаратов, применяемых как монотерапия, так и в комбинации. Подробно обсуждается роль азелаиновой кислоты в топической терапии розацеа, ее сочетание с другими терапевтическими схемами, эффективность, безопасность применения при различных подтипах заболевания.

18 March 2024 in Vestnik dermatologii i venerologii
Verified
Journal Article
Open access
PDF file
JKJulia S. Kovaleva
Julia S. Kovaleva
IKIgor Viktorovich Kazantsev
Igor Viktorovich Kazantsev
AAAnnetta Akhmedovna Aibazova
Annetta Akhmedovna Aibazova
EOEkaterina Olegovna Ovchinnikova
Ekaterina Olegovna Ovchinnikova
AGAnastasia Alexandrovna Garina
Anastasia Alexandrovna Garina
АААйбазова Аннетта Ахмедовна
Айбазова Аннетта Ахмедовна
Clinical observations of three patients aged 26, 43 and 37 years with severe psoriasis and psoriatic arthritis are presented. Clinical examples show the experience of effective treatment of patients with psoriasis and psoriatic arthritis using anti-cytokine therapy with an interleukin-17 inhibitor, initiated when the disease progresses. The clinical picture of the presented observations was characterized by an aggressive course of the skin and articular process, torpidity to basic therapy, despite the young age of the patients. It has been shown that the early termination of the progression of the inflammatory process in psoriasis with the use of genetically engineered biological therapy with secukinumab leads to a decrease in symptoms, both on the part of the skin and manifestations of the disease on the part of the musculoskeletal system. The high efficacy and safety of the drug allow complete control of the disease and improve the quality of life in patients suffering from severe forms of dermatosis.

18 August 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
YKYu. S. Kovaleva
Yu. S. Kovaleva
AVA. A. Vedler
A. A. Vedler
Introduction. The systemic psoriatic process affects not only the skin, but also other organ systems, including the cardiovascular system. Immunopathological inflammation that occurs in the skin and articular tissues is a central link in the pathology of the cardiovascular system in psoriasis.Objective. Identify diseases of the cardiovascular system and factors of their development in patients with psoriasis and to assess their severity depending on the severity of dermatosis.Materials and methods. The study included 406 patients with psoriasis aged 18 to 74 years, who were divided into three subgroups depending on the severity of the course. Assessment of the state of the cardiovascular system was carried out using the following methods: uestionnaire, clinical, physical, laboratory and statistical. The comparison group consisted of 200 people.Results. In 53.9% of patients, psoriasis occurred against the background of cardiovascular comorbidity. More than 90% of patients with moderate to severe psoriasis have more than three risk factors for CCC diseases. Patients are more susceptible to the development of hypertension, hypercholesterolemia, obesity, abdominal obesity, stress and smoking. The higher the cardiovascular risk, the more severe psoriasis is.Conclusions. The presence of unmodified and modifiable risk factors for the development of cardiovascular diseases is aggravating for the course of psoriasis, which means that the risk of undesirable fatal events is higher. Patients with psoriasis need additional preventive measures aimed at preventing the development of cardiovascular pathology.

7 June 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
JKJ. S. Kovaleva
J. S. Kovaleva
NZN. K. Zyablitskaya
N. K. Zyablitskaya
MOM. V. Orobei
M. V. Orobei
NBN. K. Bishevskaya
N. K. Bishevskaya
Allergodermatoses make up the majority of allergic skin diseases in childhood, have a recurrent course and significantly disrupt the quality of life of patients and their families. The constant use of emollients, allowing to lengthen periods of remission and reduce the need for topical drugs, is associated with defects in the skin barrier function. Treatment with topical glucocorticosteroids (TCS) and topical calcineurin inhibitors (TCI), which are the basis of pharmacotherapy, should be carried out differentially, taking into account the localization, stage and activity of the inflammatory process, the area of the lesion, the age of the child and the multifactorial genesis of the disease. The basic principles of rational local therapy include the choice of the degree of activity of the drug, its concentration, dosage form, dosage frequency, duration of use to obtain a therapeutic effect and minimize side effects. In case of severe exacerbation and localization of inflammatory elements on the body and limbs in children, it is necessary to start treatment with class 2–3 THCS. When the process is localized on the face and other sensitive areas of the skin (neck and large folds), it is recommended to use class 7 TCS or give preference to TCI. The duration of a continuous course of TCS therapy in children depends on the severity of the exacerbation and should not exceed 2 weeks. The most effective way to reduce the course steroid load and avoid side effects is the early and correct use of TCS during an exacerbation. The advantages of TCI in comparison with TCS are the low incidence of side effects, the absence of contraindications for use on sensitive skin areas, and the possibility of longer use. The article contains Russian and foreign literature data on the use of THCS and TEC in the treatment of allegodermatosis in children and our own clinical observations of the effectiveness of the use of combination therapy: Comfoderm K cream (methylprednisolone aceponate with ceramides in the base), 0.03% tacrolimus ointment and emollient means - special cream Sensoderm with physiological lipids omega 3–6–9.